Bixiye
QP13-20 Blue Cross Blue Shield National Coordination of Care SM Overview
Taariikhda uu dhaqangalayo Barnaamijka: Jan 22, 2020
Natiijooyinka Raadinta
Soo bandhiga 1441 - 1450 ee natiijooyinka 4161
Bixiye
QP6-20 Separate Remits Will be Sent for Processed Legacy Platform Runout Claims
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2020
Bixiye
QP7-20 Pharmacy Benefit Exclusion for Vyondys 53 (golodirsen)
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2020
Bixiye
QP1-20 Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Palforzia and Viaskin Peanut (Peanut Allery Oral Immunotherapy)
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2020
Bixiye
QP4-20 Minnesota Health Care Programs (MHCP) and Minnesota Senior Health Options (MSHO) Behavioral Health Fax Back Notification Update
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2020
Bixiye
QP5-20 Pharmacy Benefit Exclusions
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2020
Bixiye
QP3-20 Addition of Mille Lacs Corporate Ventures to the American Indian Tribal Fee Schedule for Eligible Facility and Professional Services Provided to Purchased/Referred Care (PRC) – Eligible American Indians
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2020
Bixiye
QP2-20 MHCP Medical Dental Claim Denials
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2020
Bixiye
QP40R1-19 Medical Drug Update for Drug Golodirsen (Vyondys 53)
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2019
Bixiye
QP40-19 Medical Drug Update for New to Market Golodirsen (Vyondys 53)
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2019